-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $9

Benzinga·10/01/2026 11:05:06
Diffusion vocale
Stifel analyst Dara Azar initiates coverage on Whitehawk Therapeutics (NASDAQ:WHWK) with a Buy rating and announces Price Target of $9.